Tardive dyskinesia: a syndrome of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with antipsychotic drugs.
Unlike previous retrospective cohort studies, the results of this large, randomized, multi-center trial clearly demonstrate the comparable efficacy of viramune and efavirenz in hiv treatment, said lead 2nn investigator professor joep lange of the international antiviral therapy evaluation center iatec ; and president of the international aids society.
Efavirenz side
SCHEMA Please provide a schema for the study. If preferred, a summary or synopsis may be provided. DO NOT USE DOSAGES OF THE DRUGS IN THIS SECTION HYPOTHESIS: Briefly state the question that this study will answer.
1. Schwinn et al., J Pharmacol. Exp. Ther, 272, 134-142, 1995 Gisbert et al., Br. J. Pharmacol., 138, 359-368, 2003. Supported by CICYT SAF2004-01541 M.Prez Aso received a fellowship from the Spanish Ministry of Education and Science, for example, efavirenz package insert.
1 Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 285 De Boer H, Blok GJ & Van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995 16 6386. Monson JP, Abs R, Bengtsson BA, Bennmarker H, FeldtRasmussen U, Hernberg-Stahl E et al. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clinical Endocrinology 2000 53 281289. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D et al. Growth hormone deficiency in adulthood and.
As noted above, efavirenz has shown strong anti-viral effects when combined with indinavir staszewski ; , and it is known to boost blood levels of nelfinavir and decrease levels of saquinavir and
sustiva.
Research Studies Center, Roswell Park Cancer Institute Buffalo, NY This program is designed to provide primary care physicians, oncologists, urologists, gastroenterologists, gynecologists, pharmacists, nurse practitioners and physician assistants with a summary of the latest data and research findings in breast, lung, GI and GU cancers presented at the 40th Annual Meeting of the American Society of Clinical Oncology ASCO ; . The program will focus on how these new data and research will impact the practice of oncology.
Table 2. Comparison of Vitamin K Antagonists with Ximelagatran and
vaseretic, for instance, efavirenz bioequivalence.
F'assays konvenzjonali dwar l-effett tossiku fuq il-eni, efavirenz ma kienx mutaeniku jew klastoeniku.
The drug market is unique. Besides market failure, the overall health condition in India has made it all the more necessary to have a stricter price control regime. Detailed discussion of these follows: The demand for medicines is uncertain and consequently becomes inevitable. A patient with a potential disease cannot afford to ignore taking medicines as the disease may turn out to be fatal or result in permanent disability, In view of the above, it becomes pertinent on the part of the patients to buy medicines as advised by their doctors irrespective of the price. Demand inelasticity of consumers thus provides added advantage to drug firms to charge a rent-seeking price and, moreover, the pre-condition of con and
ethambutol.
1. 2. 3. Sustiva. US prescribing information. DuPont Pharma; 1998. Adkins JC, Noble S. Efavirenz. Drugs 1998, 56: 10551064. Joly V., Yeni P. Non nucleoside reverse transcriptase inhibitors. AIDS Rev 1999, 1: 3744. Katlama C. Review of NNRTIs: today and tomorrow. Int J Clin Pract 1999, Suppl. 103: 1620. Bartlett J, Demasi R, Quinn J, et al. Pharmacologic considerations for therapeutic success with antiretroviral agents. 7th Conference on Retroviruses and Opportunistic Infections. San Francisco. JanuaryFebruary 2000 [Abstract 519]. Gazzard BG. What are the perceived advantages and disadvantages of non-nucleoside reverse transcriptase inhibitors as rstline therapy? HIV Med 2000, 1: 1114. Havlir D, Hicks C, Kahn J, et al. Durability of antiviral activity of efavirenz in combination with indinavir IDV ; . 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, September 1998 [Poster I-104]. Staszewski S, Morales-Ramirez J, Tashima K, et al. Efavirens plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med 1999, 341: 18651873. Luskin-Hawk R, Cohen C, Lang J, et al. Evavirenz is well tolerated and highly efcacious in combination with the nucleo.
Merck Sharp & Dohme Netherlands BV Haarlem Efavirenzz EFV ; Favirenz EFV ; 100 mg 200 mg Capsules Capsules Merck, Sharp & Dohme Ltd. Merck, Sharp & Dohme Ltd. 21 10 99 Adult Adult Antiretroviral Antiretroviral No Yes Bristol Myers Squibb Pharma Ltd, Manati Puerto Rico Yes Yes and
myambutol.
The non nucleoside reverse transcriptase inhibitors nnrtis ; nevirapine viramune ; and efavirenz sustiva ; lower plasma levels of protease inhibitors in adults and children.
Home navigation drugs by name drugs by manufacturer drugs by active ingredient drugs by availability drugs by form factor living longer, living better anti-aging and biotechnology anti-aging and hormone replacement therapy anti-aging and lifestyle anti-aging and medical conditions anti-aging and nutrition anti-aging trials and studies latest anti-aging articles tools » drug information drug information sustiva from bristol myers squibb the active ingredient in sustiva is efavirenz and
etoposide.
Various medical journals have established World Wide Web sites for readers to access publications electronically. These journal Web sites vary in their content and organization. Most of the journals provide a table of contents listing for current and past issues. Some journals provide abstracts and selected full text of articles. Search capabilities are available for some journals as well. At this time the electronic version of most journals is available at no charge, although a few of the journals require on-line registration no charge ; to view current or past issue contents. The following list of journals and Web addresses are examples of some of the journals available on-line through the Web that readers may find useful. American Academy of Family Physicians : aafp to access the following journals: American Family Physician Family Practice Management American Academy of Pediatrics : pediatrics to access the following journals: Pediatrics PEDIATRICS electronic pages, for example, efavirenz pregnancy.
Efavirenz hydrochloride
The consultant pharmacist is published by the american society of consultant pharmacists and
vepesid.
Efavirenz what is
Is optimal for use as nPEP. However, certain regimens are preferred: efavirenz and lamivudine or emtricitabine with zidovudine or tenofovir as a nonnucleoside regimen ; and lopinavir ritonavir and zidovudine with either lamivudine or emtricitabine as a protease inhibitor regimen ; . Other alternative regimens are possible, including new PIs such as atazanavir or fosamprenavir. No evidence indicates that a three-drug HAART regimen is more likely to be effective than a two-drug regimen. The recommendation for a three-drug regimen is based on the assumption that the maximal suppression of viral replication afforded by HAART will provide the best chances of preventing infection in a person who has been exposed. Secondly, for persons who have had non-occupational exposure to potentially infected body fluids of a person of unknown HIV infection status, when there is a substantial risk for HIV transmission, and if the person seeks care within 72 hours, no recommendations are made. Evaluation of the risk and benefits on a case-by-case basis must be done by the clinician in charge, with attention to potential adherence of the person exposed to a treatment with a significant rate of side effects. If the source person is available, a rapid HIV test could be of great help. Finally, for persons who seek care more than 72 hours after potential non-occupational HIV exposure, or persons with any exposure that did not represent a substantial risk for HIV transmission, nPEP is not recommended, regardless of the HIV status of the source. However, on the basis of currently available data, it is not possible to confirm that nPEP will be completely ineffective if initiated more than 72 hours after exposure. Therefore, after exposures that confer a serious risk for transmission, even if the exposed person seeks care after 72 hours, clinicians might consider the administration of nPEP. In summary, the 2005 CDC guidelines for the use of antiretroviral therapy as prophylaxis following nonoccupational exposure represent a substantial advance in the field in comparison with prior guidelines from 1998. Accumulated data about efficacy and.
Discount Efavirenz
In pregnant women, it may be desirable to initiate antiretroviral therapy after the first trimester, although for pregnant women who are severely ill, the benefit of early therapy outweighs the potential risk to the fetus. All treatment options require careful assessment by a specialist. The use of zidovudine, lamivudine, nevirapine, nelfinavir and saquinavir are recommended for women of child-bearing potential or who are pregnant. Efavrenz should be avoided because of its potential teratogenic effect on the fetus in the first trimester. First-line treatment in pregnant women should when possible include zidovudine and lamivudine. Monotherapy with either zidovudine or with nevirapine reduces transmission of infection to the neonate see also below ; , but combination antiretroviral therapy maximizes the chance of preventing transmission and represents optimal therapy for the mother. Low-dose ritonavir is required if either indinavir or saquinavir is used in pregnancy because adequate drug concentration is achieved only with ritonavir boosting. Information is lacking on the use of lopinavir with ritonavir in pregnancy. Lactic acidosis and hepatic steatosis associated with nucleoside reverse transcriptase inhibitors may be more frequent in pregnant women and therefore the combination of stavudine and didanosine should be used in pregnancy only when no alternatives are available. Protease inhibitors have been associated with glucose intolerance and pregnant women should be instructed to recognize symptoms of hyperglycaemia and to seek health care advice if they occur. Various regimens have been used to specifically prevent the transmission of HIV from mother to the neonate at term. More information is available in New Data on the Prevention of Mother-to-Child Transmission of HIV and their Policy Implications: Conclusions and Recommendations WHO RHR 01.28 ; , which reflects an interagency consultation held on 1113 October 2000. BREASTFEEDING Antiretroviral drugs may be present in breastmilk, and may reduce viral load in breastmilk and reduce the risk of transmission through breastfeeding. However, the concentration of antiretroviral drugs in breastmilk may not be adequate to prevent viral replication and there is therefore the possibility of promoting the development of drug-resistant virus which could be transmitted to the infant. Women with HIV infection should be counselled about the risks of breastfeeding and, where possible, they should limit or avoid breastfeeding; in particular, breastfeeding should be avoided where replacement feeding is acceptable, affordable, sustainable, and safe. HIV-infected women should be counselled on infant feeding options and they should be supported in their choice. POST-EXPOSURE PROPHYLAXIS Treatment with antiretroviral drugs may be appropriate following occupational exposure to HIV-contaminated material. Immediate expert advice should be sought in such cases; national guidelines on post-exposure prophylaxis for healthcare workers have been developed and local ones may also be available and
famciclovir.
This drug may not be combined with statins.
25, 2003 - an older schizophrenia drug seems to work as well as newer, vastly more expensive drugs and
femara.
A combination of these. The areas that a guideline covers depend on the illness or disorder. The recommendations in Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care cover psychological treatments, treatment with medicines, and how best to organise mental health services in order to help people with schizophrenia. The guideline concentrates on services for adults of working age with schizophrenia. It doesn't look at schizophrenia in childhood or schizophrenia that starts in later life starting over 60 years of age ; . And it doesn't look at the special problems of people with schizophrenia who also have learning difficulties, or hearing or sight problems, or at the additional problems of people with schizophrenia who also have problems with alcohol or drug misuse, or who are homeless although we say something about this, we don't look at their specific problems in a detailed way ; . The guideline will only tell you a little about diagnosis and assessment methods. These areas may be covered by future guidelines. This guideline will help you understand what kind of treatment medicines and psychological therapy ; and services are of most help to people with schizophrenia, and whether treatment is given as an outpatient, by a community mental health team, as an inpatient or in any other mental health service. It will also tell you about.
Dietary sources rich in calcium include dairy products, vegetables such as broccoli and collard greens, and sardines and
metronidazole and
efavirenz, for example, emtricitabine efavirenz.
I.Background 1. AHA first published in 1974 2. Updates: 1980, 1986, 1992, Guidelines- published simultaneously In Circulation and Resuscitation- December 13, 2005 II. BLS A. Out of hospital ABCD's no equipment is available 1. "A"IRWAY: choices i. Head-Tilt-Chin Lift -- preferred if no evidence of trauma ii. Jaw Thrust preferred if trauma involved Class IIB recommendation Note: The "lay public" will only be taught the Head-Tilt-Chin Lift Class IIA recommendation 2. "B"reathing i. Health Care Professional if no adequate breathing in 10 sec give 2 rescue breaths ii. Lay public rescue breaths not necessary if unwilling Class IIA recommendation The reasoning behind diminishing role of "rescue breathing!
Vitex: Chastetree vitex agnus-castus ; grows in subtropical areas throughout the world and has a long history of use in women's health. It is thought to have a mild hormonal-type action and therefore has been used traditionally by herbalists for a variety of female health concerns and
tamsulosin.
Increasingly, these drugs are prescribed to children.
Table 1 risk factors no of patients follow-up year 10.6 8 FEV 1-initial % 54.1 49.3 54.5 FEV 1-last % 49.8 47.9 52.5 C. Chonbasheva, T. Sulaimanova2 1 Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan 2 RAMS Institute of Occupational Health, Moscow, Russia.
Awareness of these uncommon cases is important as both UK and US treatment guidelines include efavirenz-based regimens as one of the preferred first line choices for treatment. A letter in the 25 July 2003 Issue of AIDS, reported an episode of mania in a patient without previous history of psychiatric symptoms that resolved on discontinuation. Two case studies of recurrence of post traumatic stress disorder symptoms following initiation of efavirenz-based HAART are reported in the July 2003 Issue of HIV Medicine. Both patients continured efavirrenz treatment and reported that symptom resolved to lower levels within four weeks. Both patients were refugees who recounted torture in their country of origin and were receiving treatment in the USA.
Black cohosh is comparable to pharmaceutical estrogens in treatment of hot flashes 2, for example, efavi5enz thailand.
World drug resistance epidemiology new drugs pathogenesis pharmacokinetics prevention treatment-experienced - treatment-naive treatment switch women search: more conference coverage from the body pro: 2006 2007 conference coverage all previous conference coverage upcoming conferences conference reports from other sources the body pro covers: the 12th conference on retroviruses and opportunistic infections dual nrti plus efacirenz regimen superior to boosted pi plus efavirenz coverage provided by paul sax, february 25, 2005 nucleoside-sparing regimens consisting of a protease inhibitor pi ; plus a non-nucleoside reverse transcriptase inhibitor have been studied since the original dupont 006 study, 1 which included a treatment arm of indinavir idv, crixivan ; + efavirenz efv, sustiva, stocrin and sustiva.
VALIDATION OF HEMODYNAMICS PARAMETERS OBTAINED BY NON-INVASIVE VASCULAR DIAGNOSTIC SYSTEM D. Korpas Department of Medical Biophysics, Faculty of Medicine, Palacky University, Olomouc, Czech Republic Non invasive vascular diagnostic methods to assess artery function are widely used. They are based on detection of either pressure or velocity or volume component of arterial pulse wave PW ; . PW complex physiological phenomenon spread in circulation in the course of heart systole 1 ; . The hemodynamic parameters depend on e.g. respiration and vary from pulse to pulse. The aim of this study was to assess the stability of most used approaches. System used in this study is based on the detection of volume PW of surface artery. The new in this method is the way PW is taken. The artery volume changes, evoked by the PW, are measured through an adhesive, very thin membrane, which is enclosed, to the palpation spot near the artery. The volume changes, affecting the fluid behind the membrane, transfer themselves into pressure changes and move towards the positive input of a very sensitive differential pressure transducer. The differential pressure transmitter converts the pressure differences to electrical voltage. This system offers high sensitivity to volume changes of artery diameter. The output of transducer is connected to the measuring PC. The computer analyzing system is built in LabView software and allows measurement of arbitrary hemodynamic parameters within the time and frequency domain. The PW evaluated parameters were the following: crest time, interwave distance, elasticity index 2 ; , systolic amplitude, dicrotic time, dicrotic amplitude, and Aix 3 ; . The complex parameter was PW velocity. The whole PW course can be submitted to first, second derivation or FFT. Some parameters correlate. Most parameters vary from pulse to pulse in the range of 10% because of the low circulatory rhythms in blood pressure. Using the first or second derivation of PW course can prevent this variation. The parameters using time intervals have better stability than those using amplitude ones do. 1. Korpas D.: Cs. Fyziol. 52: 152-158, 2003. Oliva I., Roztocil K.: Physiol. Bohemoslov. 29: 333-341, 1980. Aggoun Y., Beghetti M.: Images Paediatr. Cardiol. 13: 12-18, 2002.
Efavirenz sale
Questions have also been raised as to whether the drug is apt to cause birth defects in fetuses that are inadvertently exposed to it, either because the contraceptiove fails or a woman is unwittingly pregnant at the time she receives the injection.
LEVOFLOXACIN IV ONLY ; Severe community acquired or hospital acquired pneumonia in penicillin allergic patients Strictly 2nd line in accordance with BTS guidelines ie plus benzylpenicillin ; for severe pneumonia in hospitalised patients Severe community acquired pneumonia associated with travel abroad MOXIFLOXACIN ORAL ONLY ; Step down from IV levofloxacin in severe CAP Hospital Acquired Pneumonia in penicillin allergic patients VORICONAZOLE Voriconazole can only be prescribed on recommendation of an ID Specialist or microbiologist For treatment of fluconazole resistant serious invasive candida infections Haematology patients with possible intracerebral invasive fungal infection Invasive fungal infections in haematology patients where oral step down is appropriate CASPOFUNGIN For treatment of fluconazole resistant invasive candidiasis as an alternative to amphotericin on recommendation of an ID Specialist or microbiologist Empirical treatment of sepsis in haematology patients after 96 hours of treatment with antibacterial therapy and continuing fever. If prescribed prior to 96 hours it must be discussed with ID specialist or microbiologist VALGANCICLOVIR Valganciclovir can only be prescribed on recommendation of an ID Specialist or microbiologist Oral prodrug of ganciclovir licensed for treatment of CMV retinitis in HIV patients and CMV in solid organ transplant patients ANTIVIRAL TREATMENTS FOR HIV INFECTION These are only to be prescribed by HIV specialists in hospital. The following are approved for use: Non-nucleoside reverse transcriptase inhibitors Nevirapine Efavirenz Nucleotide reverse transcriptase inhibitor Tenofovir Nucleoside reverse transcriptase inhibitors Zidovudine Lamivudine Abacavir Stavudine Didanosine Combivir zidovudine lamivudine ; Kirexa abacavir lamivudine.
Veldkamp AI, Harris M, Montaner JSG, et al. The steady-state pharmacokinetics of efavirenz und nevirapine when used in HIV-1 infected patients. J Infect Dis 2001; 184: 37-42. : amedeo lit ?id 11398107 Wire MB, Ballow C, Preston SL, et al. Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers. AIDS 2004, 18: 897-907. : amedeo lit ?id 15060437 Klein C, ZHU T, Chiu YL et al. Effect of efavirenz on lopinavir ritonavir pharmacokinetics from a new tablet formulation. Abstract 4.3 2, 10th EACS 2005, Dublin. Alvarez-Amao D, Pace W, Gold M. Switch from high to low dose amprenavir in combination with efavirenz and ritonavir. Abstract 2.7, 3rd Int Worksh Clin Pharmacol HIV Ther 2002, Washington. Preston S, Piliero P, OMara E, et al. Evaluation of steady-state interaction between atazanavir and efavirenz. Abstract 433, 9th CROI 2002, Seattle. ReyatazTM, Bristol-Myers Squibb. Aarnoutse RE, Grintjes KJT, Telgt DS, et al. The influence of efavirenz on the pharmacokinetics of a twice daily combination of indinavir and low-dose ritonavir in healthy subjects. JAIDS 2003; 34: 134-9. : amedeo lit ?id 11823758 Boyd MA, Aarnoutse RE, Ruxrungtham K, et al. Pharmacokinetics of indinavir ritonavir 800 100 mg ; in combination with efavirenz 600 mg ; in HIV-infected subjects. JAIDS 2003; 34: 134-9. : amedeo lit ?id 14526202 Bertz R, Lam W, Hsu A, et al. Assessment of the pharmacokinetic interaction between ABT 378 r and efavirenz in healthy volunteers and in HIV + subjects. Abstract 424, 40th ICAAC 2000, Toronto. Jorga K, Buss NE. Pharmacokinetic drug interaction with saquinavir sgc. Abstract 339, 39th ICAAC 1999, San Francisco. Hendrix CW, Fiske WD, Fuchs EJ, et al. Pharmacokinetics of the triple combination of saquinavir, ritonavir and efavirenz in HIV + subjects. Abstact 424, 11th CROI 2000, San Francisco. van Heeswijk RP, Cooper C, Gallicano A, et al. The pharmacokinetics of SQV RTV 400 mg BID before, and after short- and long term co-administration of efavirenz 600 mg QD. Abstract 7.4, 3rd Int Worksh Clin Pharmacol HIV-Ther 2002, Washington. Lopez-Cortes LF, Viciana P, Ruiz-Valderas R, et al. Pharmacokinetics, efficacy and safety of oncedaily saquinavir-sgc plus low-dose ritonavir 1200 100 mg ; in combination with efavirenz in HIVpretreated patients. Abstract 441, 9th CROI 2002, Seattle. Fiske WD, Benedek IH, White SJ, et al. Pharmacokinetic interaction between efavirenz and nelfinavir mesylate in healthy volunteers. Abstract 349, 5th CROI 1998, Chicago. Benedek ICH, Joshi A, Fiske WD, et al. Pharmacokinetic studies in healthy volunteers with efavirenz and the macrolide antibiotics, azithromycin and clarithromycin. Abstract 347, 5th CROI 1998, Chicago. Clinical Pharmacology, Gold Standard Multimedia, 2004. : gsm Pratt CM, Mason J, Russell T. Cardiovascular safety of fexofenadine HCL. J Cardiol 1999; 84: 278-9. : amedeo lit ?id 10335761 Abernethy DR, Barbey JT. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QT-prolongation. Clin Pharmacol Ther 2001; 69: 96-103. : amedeo lit ?id 11240972 VfendTM, Pfizer. Michalets E: Update: Clinically Significant Cytochrome P-450 Drug Interaction. Ann Pharmacother 1998; 18: 84-112. : amedeo lit ?id 9469685 Rossi DR, Rathbun C, Slater LD. Symptomatic ortostasis with extended-release nifedipine and protease inhibitors. Ann Pharmacother 2002; 22: 1312-16. : amedeo lit ?id 12389881 Gerber JG, Fichtenbaum CJ, Rosenkranz S, et al. Efavirenz is a significant inducer of simvastatin and atorvastatin metabolism: results of ACTG A5108 study. Abstract 603, 11th CROI 2004, San Francisco. Fichtenbaum CJ, Gerber JG, Rosenkranz S. Pharmacokinetic interaction between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. AIDS 2002; 16: 569-77. : amedeo lit ?id 11873000 Doser N, Kubli S, Telenti A. Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitortreated HIV-infected patients. AIDS 2002; 16: 1982-3. : amedeo lit ?id 12351967.
| Buy cheap Efavirenz onlineOther macrolide antibiotics, such as erythromycin, have not been studied in combination with efavirenz.
The protease inhibitors indinavir, saquinavir, and nelfinavir have much less effect on psychotropic drug levels, but may inhibit cytochrome p450 3a the nonnucleotide reverse transcriptase inhibitors efavirenz and delavirdine also can inhibit cyp 3a therefore, triazolam and pimozide should be avoided with these medications.
Elderly: insufficient numbers of elderly patients have been evaluated in clinical studies to determine whether they respond differently than younger patients. Children: efavirenz has not been evaluated in children below 3 years of age or who weigh less than 13 kg. Therefore, efavirenz should not be given to children less than 3 years of age. Lactose: this medicinal product contains 250 mg of lactose in each 600-mg daily dose. This quantity is not likely to induce symptoms of lactose intolerance Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. Individuals with these conditions may take efavirenz oral solution, which is free from lactose. 4.5 Interaction with other medicinal products and other forms of interaction.
History of Efavirenz
|
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study Carlo Carella et al., and Giovanni Amato Department of Clinical and Experimental Medicine, Second University of Naples, Italy Clin Endocrinol 57: 507-513, 2002.
